JP2024534032A5 - - Google Patents

Info

Publication number
JP2024534032A5
JP2024534032A5 JP2024508945A JP2024508945A JP2024534032A5 JP 2024534032 A5 JP2024534032 A5 JP 2024534032A5 JP 2024508945 A JP2024508945 A JP 2024508945A JP 2024508945 A JP2024508945 A JP 2024508945A JP 2024534032 A5 JP2024534032 A5 JP 2024534032A5
Authority
JP
Japan
Prior art keywords
diaminopyridine
composition according
subject
botulism
pharmaceutically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024508945A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024534032A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/074849 external-priority patent/WO2023023463A1/en
Publication of JP2024534032A publication Critical patent/JP2024534032A/ja
Publication of JP2024534032A5 publication Critical patent/JP2024534032A5/ja
Pending legal-status Critical Current

Links

JP2024508945A 2021-08-19 2022-08-11 ボツリヌス毒素中毒を処置するための方法 Pending JP2024534032A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163234970P 2021-08-19 2021-08-19
US63/234,970 2021-08-19
PCT/US2022/074849 WO2023023463A1 (en) 2021-08-19 2022-08-11 Method for treating botulinum toxin poisoning

Publications (2)

Publication Number Publication Date
JP2024534032A JP2024534032A (ja) 2024-09-18
JP2024534032A5 true JP2024534032A5 (https=) 2025-08-06

Family

ID=85239795

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024508945A Pending JP2024534032A (ja) 2021-08-19 2022-08-11 ボツリヌス毒素中毒を処置するための方法

Country Status (4)

Country Link
US (1) US20230074200A1 (https=)
EP (1) EP4387620A4 (https=)
JP (1) JP2024534032A (https=)
WO (1) WO2023023463A1 (https=)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4734275A (en) * 1983-08-19 1988-03-29 Research Corporation Anti-curare agents
FR2820423B1 (fr) * 2001-02-05 2005-12-02 Assist Publ Hopitaux De Paris Tartrate et phosphate de 3,4-diaminopyridine, compositions pharmaceutiques et utilisations
US20080118553A1 (en) * 2006-06-12 2008-05-22 Anton Frenkel Tannate salt form of polypeptide mixtures, their preparation and use
WO2014189830A1 (en) * 2013-05-20 2014-11-27 University Of Pittsburgh-Of The Commonwealth System Of Higher Education Calcium channel agonists

Similar Documents

Publication Publication Date Title
Crowther et al. Management of adult acute myelogenous leukaemia
JP2025020134A5 (https=)
JP2023535744A5 (https=)
Siimes et al. Synergistic action of two polyamine antimetabolites leads to a rapid therapeutic response in childhood leukemia
RU2018121615A (ru) Модуляторы активности комплемента
JP2023524039A5 (https=)
Duquette et al. Isoniazid for tremor in multiple sclerosis: a controlled trial
JP2025148449A5 (https=)
US20260102374A1 (en) Methods of treating bacterial infections
JP5837877B2 (ja) 静脈内投与イブプロフェンを用いた患者の治療
KR20120138229A (ko) 정맥내 투여용 이부프로펜을 이용한 중증 환자의 치료
JP2024534032A5 (https=)
JP2022553888A5 (https=)
JP2024512558A5 (https=)
TSUDA et al. Toxicological study on antineoplastons A-10 and AS2-1 in cancer patients
West et al. Sudden hypotension associated with midazolam and sufentanil
KR20000005479A (ko) 약독화된 비면역원성 폭스 바이러스 또는 파라폭스 바이러스로부터 멀티포텐트 파라폭스 면역 유발인자의 약제로서 이용하는새로운 적용
JP2024543347A5 (https=)
Hollister et al. Plasma concentrations of choline in man following choline chloride
JP2022546042A5 (https=)
JP3064815B2 (ja) ミエローマ系腫瘍抗癌剤
CN113332437A (zh) Sur1抑制剂与藏花酸或其可药用盐联合作为神经保护剂的用途
JP2022525779A5 (https=)
Citrome et al. 169 Dasotraline for Treatment of Adults with Binge-Eating Disorder: Effect on Binge-related Obsessions and Compulsions
Schellong et al. Microcirculation and tolerability following iv infusion of PGE1 and iloprost: a randomized cross-over study in patients with critical limb ischemia